Monsanto shareholders back Bayer deal, CEO hopeful of U.S. approval

CHICAGO (Reuters) - Shareholders of U.S. seeds and agrochemicals company Monsanto Co approved the company's $66 billion acquisition by Bayer AG on Tuesday, a deal that still requires regulatory approval to close as expected in late 2017.

Monsanto shareholders back Bayer deal, CEO hopeful of U.S. approval
Read More


Bagikan Berita Ini